Filing Details
- Accession Number:
- 0001093557-20-000333
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-29 20:58:42
- Reporting Period:
- 2020-12-28
- Accepted Time:
- 2020-12-29 20:58:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1692785 | Michael Patrick Murphy | 6340 Sequence Drive San Diego CA 92121 | Evp, Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-28 | 500 | $355.39 | 19,078 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- Included in this number are 17,471 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,803 of which were granted on March 8, 2018 and shall vest through March 8, 2021.